Flexion Therapeutics, Inc. (FLXN) Social Stream
Flexion Therapeutics Inc (FLXN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Flexion Therapeutics Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 11 | $27 | $6 | $18 | $9.29 | 93.76% |
The Trend in the Analyst Price Target
Over the past 67 days, FLXN's average price target has gone down $1.25.
Over the past 16 months, FLXN's average upside potential has been 130.71%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-15 | 11 | 27 | 6 | 18.00 | 6.32 | 184.81% |
| 2021-09-11 | 11 | 27 | 6 | 18.00 | 6.05 | 197.52% |
| 2021-08-09 | 12 | 27 | 6 | 18.00 | 5.45 | 230.28% |
| 2021-08-07 | 12 | 27 | 6 | 18.00 | 5.70 | 215.79% |
| 2021-08-05 | 12 | 35 | 8 | 19.25 | 6.50 | 196.15% |
| 2021-08-01 | 12 | 35 | 8 | 19.25 | 5.93 | 224.62% |
| 2021-07-24 | 12 | 35 | 8 | 19.25 | 6.38 | 201.72% |
| 2021-07-17 | 12 | 35 | 8 | 19.25 | 6.71 | 186.89% |
| 2021-07-10 | 12 | 35 | 8 | 19.25 | 7.82 | 146.16% |
| 2021-06-21 | 13 | 35 | 8 | 19.15 | 9.15 | 109.29% |
| 2021-06-13 | 13 | 35 | 8 | 19.15 | 9.30 | 105.91% |
| 2021-06-05 | 13 | 35 | 8 | 19.15 | 8.49 | 125.56% |
| 2021-04-26 | 13 | 35 | 11 | 19.77 | 8.66 | 128.29% |
| 2021-04-25 | 13 | 35 | 11 | 19.77 | 8.16 | 142.28% |
| 2021-04-17 | 13 | 35 | 11 | 19.77 | 9.41 | 110.1% |
| 2021-03-23 | 13 | 35 | 15 | 20.38 | 9.74 | 109.24% |
| 2021-03-20 | 13 | 35 | 15 | 20.38 | 10.18 | 100.2% |
| 2021-03-13 | 13 | 35 | 15 | 20.38 | 11.84 | 72.13% |
| 2021-02-01 | 12 | 35 | 15 | 20.17 | 12.95 | 55.75% |
| 2021-01-30 | 13 | 35 | 15 | 20.69 | 12.17 | 70.01% |
| 2021-01-23 | 13 | 35 | 16 | 20.77 | 11.54 | 79.98% |
| 2021-01-16 | 12 | 27 | 16 | 19.58 | 13.06 | 49.92% |
| 2021-01-09 | 11 | 25 | 16 | 18.91 | 12.32 | 53.49% |
| 2020-11-26 | 13 | 35 | 16 | 20.77 | 10.84 | 91.61% |
| 2020-11-14 | 12 | 35 | 16 | 20.50 | 11.38 | 80.14% |
| 2020-10-16 | 12 | 35 | 15 | 20.58 | NA | NA% |
| 2020-09-27 | 12 | 35 | 15 | 20.67 | NA | NA% |
| 2020-08-31 | 12 | 35 | 15 | 20.67 | NA | NA% |
| 2020-08-19 | 12 | 35 | 15 | 20.75 | NA | NA% |
| 2020-07-29 | 11 | 35 | 17 | 21.27 | NA | NA% |
| 2020-07-22 | 9 | 35 | 17 | 21.78 | NA | NA% |
| 2020-07-14 | 9 | 35 | 17 | 21.78 | NA | NA% |
| 2020-07-11 | 9 | 35 | 17 | 21.89 | NA | NA% |
| 2020-06-24 | 9 | 35 | 17 | 21.89 | NA | NA% |
| 2020-06-15 | 8 | 35 | 17 | 21.50 | NA | NA% |
| 2020-05-22 | 8 | 35 | 17 | 21.50 | NA | NA% |
FLXN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.55 | 2 | 5 | 3 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 122 days, FLXN's average broker recommendation rating worsened by 0.14.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FLXN as an investment opportunity.
- FLXN has a lower variance in analysts' estimates than 2.87% of all US stocks.
- Flexion Therapeutics Inc's number of analysts covering the stock is greater than 99.07% of stocks in the small market cap category.
- FLXN has a higher upside potential (average analyst target price relative to current price) than 80.61% of all US stocks.
- FLXN has a higher average analyst price target than 33.61% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Flexion Therapeutics Inc are SGMO, DRNA and AVRO.
Is FLXN a Buy, Hold or Sell? See the POWR Ratings now!